Projects per year
Personal profile
Interests
I trained in haematology and general medicine in Belfast and then in the Royal Postgraduate Medical school, Hammersmith Hospital. I was appointed senior lecturer in 1991 and have been an active researcher and clinician in haematological malignancy in Belfast since that time.
Other
Key Words
Myeloproliferative Disorders, Polycythaemia Vera, Idiopathic Erythrocytosis, Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia and Clinical Trials.
Grants
I have received funding for Clinical Training Fellows from the Medical Research Council, Leukaemia Research Fund and the Research and Development Office Northern Ireland.
Myeloproliferative Disorders, Polycythaemia Vera, Idiopathic Erythrocytosis, Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia and Clinical Trials.
Grants
I have received funding for Clinical Training Fellows from the Medical Research Council, Leukaemia Research Fund and the Research and Development Office Northern Ireland.
Research Statement
Research
My main research interests are in myeloproliferative disorders, acute myeloid leukaemia and chronic myeloid leukaemia. I have an active clinical practice and collaborate with scientists looking at the pathogenesis of the myeloproliferative disorders and in particular investigations of patients with idiopathic erythrocytosis. I also work on the pathogenesis and treatment of Acute Myeloid Leukaemia and Chronic Myeloid Leukaemia.
My main research interests are in myeloproliferative disorders, acute myeloid leukaemia and chronic myeloid leukaemia. I have an active clinical practice and collaborate with scientists looking at the pathogenesis of the myeloproliferative disorders and in particular investigations of patients with idiopathic erythrocytosis. I also work on the pathogenesis and treatment of Acute Myeloid Leukaemia and Chronic Myeloid Leukaemia.
Clinical Trials
With the clinical trials unit we have a number of phase three and phase two trials in the areas of acute myeloid leukaemia and chronic myeloid leukaemia and myeloproliferative disorders. We continually investigate for new and improved treatments in these disorders.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Mary Frances McMullin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
R2409CPH: Myeloproliferative neoplasmS: An In-depth Case-Control (MOSAICC) Study
McShane, C. (PI) & McMullin, M. F. (CoI)
31/05/2017 → …
Project: Research
-
R2541CPH: Myeloproliferative neoplasmS: An In-depth Case-Control (MOSAICC) study
McShane, C. (PI) & McMullin, M. F. (CoI)
19/11/2018 → 31/05/2021
Project: Research
-
R1785CNR: The role of c-FLIP in regulating response to chemotherapy in AM Leukeumia
Longley, D. (PI) & McMullin, M. F. (CoI)
01/08/2006 → 31/07/2009
Project: Research
-
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial
McIlroy, G., Gaskell, C., Jackson, A., Yafai, E., Tasker, R., Thomas, C., Fox, S., Boucher, R., Ghebretinsea, F., Harrison, C., Mead, A. J. & McMullin, M. F., 10 Jan 2025, In: BMC Cancer. 25, 1, 11 p., 56.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
Estcourt, L. J., McQuilten, Z. K., Bardy, P., Cole-Sinclair, M., Collins, G. P., Crispin, P. J., Curnow, E., Curnow, J., Degelia, A., Dyer, C., Friebe, A., Floro, L., Grand, E., Hudson, C., Jones, G., Joseph, J., Kallmeyer, C., Karakantza, M., Kerr, P. & Last, S. & 31 others, , Jan 2025, In: The Lancet Haematology. 12, 1, p. e14-e22Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)3 Downloads (Pure) -
Analysis of real-world data demonstrating the efficacy of current management of polycythaemia vera in attaining and maintaining therapeutic haematocrit
Buckley, F. D., Arnold, C., Brass, D., Catherwood, M. & McMullin, M. F., Apr 2024, In: Irish Journal of Medical Science. 193, 2, p. 833-836 4 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Association between JAK2 V617F variable allele frequency and risk of thrombotic events in patients with myeloproliferative neoplasms
Brown, R., Jasiakiewicz, J., Greer, V., Hindley, A., McDowell, K., Devlin, E., Clarke, K., Buckley, F., Crean, C., McGimpsey, J., Cuthbert, R. J. G., Cunningham, N., Arnold, C., Finnegan, D., Benson, G., McMullin, M. F. & Catherwood, M. A., 14 Aug 2024, (Early online date) In: Irish Journal of Medical Science. 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias
Pietka, G., De Lord, C., Matthias, G., Cheung, B., Atwal, S., Furtado, M., Cullis, J., Grey-Davies, L., Narayanan, S., McGregor, A., Kilner, M., Bosworth, J., McMullin, M. F., Coats, T., Parcharidou, A., Cavenagh, J., Byrne, J., Iyengar, S., Mohammed, K. & Cross, N. & 6 others, , Apr 2024, In: British Journal of Haematology. 204, 4, p. 1325-1334 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile
-
Cancers (Journal)
McMullin, M. F. (Peer reviewer)
01 May 2020Activity: Publication peer-review and editorial work types › Editorial activity
-
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (Journal)
McMullin, M. F. (Associate editor)
01 Jan 2008Activity: Publication peer-review and editorial work types › Publication peer-review
Press/Media
-
MPDLife June 2014
Anderson, L. & McMullin, M. F.
01/06/2014
1 item of Media coverage
Press/Media: Public Engagement Activities
-
MPDLife November 2013
Anderson, L. & McMullin, M. F.
01/11/2013
1 item of Media coverage
Press/Media: Public Engagement Activities
-
MPDLife March 2013
Anderson, L. & McMullin, M. F.
01/03/2013
1 item of Media coverage
Press/Media: Public Engagement Activities
-
MPDLife May 2012
Anderson, L. & McMullin, M. F.
01/05/2012
1 item of Media coverage
Press/Media: Public Engagement Activities
Impacts
-
Identifying Patients with Rare Forms of Erythrocytosis
McMullin, M. F. (Participant), Lappin, T. (Participant) & Hughes, A. (Participant)
Impact: Health Impact, Quality of Life Impact